Table 3 Clinical characteristics of 30 renal transplant recipients with post-transplantation visceral leishmaniasis
Variable | Mean (SD)* | n(%) | P-value ** |
|---|---|---|---|
Number of blood transfusions before RTx | 0.80 (0.66) | - | - |
Median time between RTx and VL (months) | 28 | - | - |
Mean time between RTx and VL (months) | 21.3 (16.15) | - | - |
Acute rejection episode | 0.93 (0.74) | - | - |
Blood transfusion before RTx | |||
Yes | 13 (43.3) | 0.465 | |
No | 17 (56.7) | ||
Blood type of recipient | |||
Serotype O | 14 (46.7) | 0.025 | |
Serotype A | 13 (43.3) | ||
Serotype B | 3 (10.0) | ||
Rh∞ factor of recipient | |||
Positive | 22 (73.3) | 0.011 | |
Negative | 8 (26.7) | ||
Incompatible mismatches, recipient–donor | |||
≤3 mismatches | 25 (83.3) | 0.001 | |
>3 mismatches | 5 (16.7) | ||
Use of prednisone | |||
Yes | 30 (100.0) | - | |
No | 0 (0.0) | ||
Use of azathioprine | |||
Yes | 6 (20.0) | 0.001 | |
No | 22 (80.0) | ||
Use of cyclosporine | |||
Yes | 11 (36.7) | 0.200 | |
No | 19 (63.3) | ||
Use of tacrolimus | |||
Yes | 17 (56.7) | 0.565 | |
No | 13 (43.3) | ||
Use of MMF♯ | |||
Yes | 27 (90.0) | 0.000 | |
No | 3(10.0) | ||
Induction with monoclonal antibody | |||
Yes | 21 (70.0) | 0.043 | |
No | 9 (30.0) | ||
Acute rejection post-transplantation | |||
Yes | 12 (40.0) | 0.362 | |
No | 18 (60.0) | ||
Patients with VL before RTx | |||
Yes | 0. (0.0) | ||
No | 30 (100.0) | - | |
CMV≠ infection post-transplantation | |||
Yes | 12 (40.0) | 0.362 | |
No | 18 (60.0) | ||
Bacterial infection post-transplantation | |||
Yes | 11 (36.6) | 0.002 | |
No | 19 (73.4) | ||
Recipient with positive serology for other viruses | |||
No | 20 (66.7) | 0.068 | |
Yes | 10 (27.0) |